Pillstats
Rx only · Tablet · Oral

Olmesartan Medoxomil

Olmesartan Medoxomil

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US23 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)118463
US makers9 labelers
Packages55
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.025$0.051$0.076$0.101Dec 2025Apr 2026Jul 2026
$0.085
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
9
Active US suppliers
38%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

15K29K44K58K2025 Q12025 Q22025 Q32025 Q42026 Q1
51K
Rx · 2026 Q1
2.9M
Units dispensed
+18%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Macleods Pharmaceuticals Limitedunknown12SUPPLYING
Umedica Laboratories USA Inc.unknown9SUPPLYING
Solco Healthcare US, LLCunknown9SUPPLYING
Bryant Ranch Prepackrepackager7SUPPLYING
Lifestar Pharma LLCunknown6SUPPLYING
A-S Medication Solutionsunknown6SUPPLYING
Chartwell RX, LLCunknown3SUPPLYING
Direct_Rxunknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.